Additionally, MMR status emerged as a significant prognostic factor in populations with colon as the primary site, lymph node metastasis, adenocarcinoma, mucinous adenocarcinoma and signet-ring cell carcinoma. This evidence concerns the gene MRC1 and metastatic malignant neoplasm in the lymph nodes.